The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Redicare Nasal and Sinus Decongestant
Redicare Nasal and Sinus Decongestant · PHENYLEPHRINE HYDROCHLORIDE 10 mg/1 · Tablet · Oral · Redicare LLC
NDC 71105-0272-02 · 50 PACKET in 1 BOX / 2 TABLET in 1 PACKET · OTC MONOGRAPH DRUG · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- M012
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Redicare Nasal and Sinus Decongestant (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Redicare LLC | PHENYLEPHRINE HYDROCHLORIDE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Redicare Nasal and Sinus Decongestant — NDC 71105-0272-02," retrieved September 3, 2026, https://drugdashboards.com/drug/71105027202.
Free to cite with attribution — see how the data is put together.